Category: Cancer

Posted on

Enhertu

Enhertu (fam-trastuzumab deruxtecan-nxki) is a cancer treatment drug that was approved by the US Food and Drug Administration (FDA) in December 2019. It is used to treat certain types of breast cancer that are HER2-positive, meaning that the cancer cells have an overproduction of a protein called HER2. Enhertu is a type of antibody-drug conjugate (ADC), which delivers a powerful chemotherapy drug directly to cancer cells.

How Enhertu Works

Enhertu works by binding to the HER2 protein on cancer cells and delivering a chemotherapy drug to destroy the cancer cells. It is typically administered intravenously, meaning it is delivered into a vein through an IV.

It’s important to note that not all patients will respond to Enhertu, and the drug can have side effects. It’s best to speak with a doctor to determine if Enhertu is the right treatment option for you. They can provide more information on the potential benefits and risks of the drug, and help you make an informed decision about your treatment.

Her2-Low Treatment – Enhertu

HER2-low breast cancer refers to a type of breast cancer where the cancer cells have a low expression of the HER2 protein. HER2 is a protein that helps regulate cell growth and division, and it is often overproduced in certain types of breast cancer, leading to more aggressive and rapid tumor growth.

Treatment for HER2-low breast cancer typically involves a combination of surgery, radiation therapy, and/or systemic therapy (such as chemotherapy, hormone therapy, or targeted therapy). The specific treatment plan will depend on a number of factors, including the stage and location of the cancer, the patient’s overall health, and any other medical conditions they may have.

In general, systemic therapy is the mainstay of treatment for HER2-low breast cancer. Chemotherapy is a common choice for treating HER2-low breast cancer, as it can shrink the size of the tumor and kill cancer cells that have spread to other parts of the body. Hormone therapy may also be used to treat HER2-low breast cancer, particularly in cases where the cancer is hormone receptor-positive. Targeted therapy may also be used in some cases, depending on the specific type of HER2-low breast cancer.

It’s important to work closely with a healthcare team to determine the best treatment plan for your specific situation. They can help you understand the options available and the potential benefits and risks of each.

METASTATIC BREAST CANCER: ENHERTU STOPS THE SPREAD

One in eight women will be diagnosed with breast cancer in their lifetime. Breast cancer is the second leading cause of cancer death for women, behind lung cancer, but after years of clinical trials, the FDA recently approved an exciting new targeted therapy for women with metastatic HER2-low cancer.

Enhertu Breast Cancer

Enhertu (fam-trastuzumab deruxtecan-nxki) is a treatment drug for certain types of HER2-positive breast cancer. HER2-positive breast cancer is a type of breast cancer where the cancer cells have an overproduction of the HER2 protein, which can lead to more aggressive and rapid tumor growth. Enhertu is a type of antibody-drug conjugate (ADC) that delivers a powerful chemotherapy drug directly to cancer cells.

Enhertu works by binding to the HER2 protein on cancer cells and delivering a chemotherapy drug to destroy the cancer cells. It is typically administered intravenously, meaning it is delivered into a vein through an IV.

In clinical trials, Enhertu has been shown to be effective in treating HER2-positive breast cancer that has spread to other parts of the body (metastatic breast cancer). It has also been shown to be effective in patients who have received prior treatment with other HER2-targeted therapies, including trastuzumab (Herceptin) and pertuzumab (Perjeta).

It’s important to note that not all patients will respond to Enhertu, and the drug can have side effects. It’s best to speak with a doctor to determine if Enhertu is the right treatment option for you. They can provide more information on the potential benefits and risks of the drug, and help you make an informed decision about your treatment.

Latest Stories

Posted on

Mesothelioma Lawsuit – Mesothelioma Class Action Lawsuit

Mesothelioma Class Action Lawsuit and Mesothelioma lawsuit process. You will learn more of what are the first steps in filling a lawsuit.

Law firms have represented many hundreds of people with cancer, especially people suffering from mesothelioma, a cancer whose only known cause is exposure to asbestos. In this article, you will learn more of what are the first steps in filling a Mesothelioma lawsuit.

The first thing you would do is contact law firm office for Mesothelioma Lawsuit. One of firm intake representative will take your information and create a file for your possible case, that file will be circulated to a number of people whose job it is to review the file and determine what type of a case this is. If law firm feel that your case is one we could prosecute, then they will contact you and they will ask you if you would like to sign up with them, from that point you would sign a retainer and then they would begin work on your case.

Once you have decided to enter an retainer agreement with law firm office, they would create a file, that file would be passed to a case management team. They would begin work up on the case and they would begin by filing out which defendants belong in your case from, that point law firm would do their best to file a complaint as soon as possible.

After the complaint is filed then they begin discovery process which will include written discovery as well as your deposition possibly the deposition of your spouse or family members and then other witnesses an the case. At that point it all depends on when the trial date is set but law firm will procced to trial as needed.

Mesothelioma Cases

Featured Latest Articles

Exit mobile version